Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.02
0.055.13%
At close: -
$0.9892
-0.03-3.02%
After Hours: 7:59 PM EDT
Comments
Loading...
Opus Genetics (IRD) Forecast
NewsEarningsOpus Genetics (IRD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Opus Genetics Stock Price, Quotes and Forecasts | NASDAQ:IRD | Benzinga
Explore Opus Genetics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IRD.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Opus Genetics (IRD) stock?
You can purchase shares of Opus Genetics (NASDAQ:IRD) through any online brokerage.
Who are Opus Genetics (IRD) competitors?
Other companies in Opus Genetics’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Adverum Biotechnologies (NASDAQ:ADVM) and Gain Therapeutics (NASDAQ:GANX).
What is the forecast, or price target, for Opus Genetics (IRD) stock?
Opus Genetics has a consensus price target of $6.75.
What is the current price for Opus Genetics (IRD)?
The stock price for Opus Genetics (NASDAQ: IRD) is $0.9892 last updated June 26, 2025 at 7:59 PM EDT.
Does Opus Genetics (IRD) pay a dividend?
There are no upcoming dividends for Opus Genetics.
When is Opus Genetics (NASDAQ:IRD) reporting earnings?
Opus Genetics’s Q2 earnings are confirmed for Friday, August 15, 2025.
Is Opus Genetics (IRD) going to split?
There is no upcoming split for Opus Genetics.
What sector and industry does Opus Genetics (IRD) operate in?
Opus Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
